← Insider buys

FLXN

Horizon Flexible Income ETF

No insider bought or sold Horizon Flexible Income ETF in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo

FLXN over the last year

No insider buys filed in this year

FLXN after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

46 insider filings since 2016, newest first

FLXNSell

Kerry Wentworth · Chief Regulatory Officer

$25K−3.0%Jul 20
FLXNSell

Christina Willwerth · Chief Strategy Officer

$25K−3.0%Jul 20
FLXNSell

Mark S. Levine · General Counsel

$25K−3.0%Jul 20
FLXNSell

Melissa Layman · Chief Commercial Officer

$53K−4.0%Mar 16
FLXNSell

Melissa Layman · Chief Commercial Officer

$33K−3.0%Jan 29
FLXNSell

Kerry Wentworth · Chief Regulatory Officer

$76K−5.0%Jan 7
FLXNSell

Adam Muzikant · Chief Business Officer

$45K−5.0%Jan 7
FLXNSell

Scott Kelley · Chief Medical Officer

$76K−6.0%Jan 7
FLXNSell

Christina Willwerth · Chief Strategy Officer

$73K−5.0%Jan 7
FLXNSell

Mark S. Levine · General Counsel

$76K−6.0%Jan 7
FLXNSell

David Arkowitz · CFO

$68K−4.0%Jan 7
FLXNBuy

Michael D. Clayman · President and CEO

$100K+1.0%May 27
FLXNSell

David Arkowitz · CFO

$26K−2.0%May 11
FLXNBuy

Michael D. Clayman · President and CEO

$25KAug 8
FLXNBuy

David Arkowitz · CFO

$28K+3.0%Jun 3
FLXNBuy

C Ann Merrifield · Director

$101K+400.0%May 24
FLXNBuy

David Arkowitz · CFO

$48K+5.0%May 15
FLXNBuy

Michael D. Clayman · President and CEO

$50K+1.0%May 13
FLXNBuy

Michael D. Clayman · President and CEO

$50K+1.0%Mar 13
FLXNSell

Michael D. Clayman · President and CEO

$41KJan 4
FLXNBuy

Michael D. Clayman · President and CEO

$85K+1.0%Nov 13
FLXNBuy

David Arkowitz · CFO

$66K+9.0%Nov 13
FLXNBuy

David Arkowitz · CFO

$94K+10.0%Aug 10
FLXNBuy

Michael D. Clayman · President and CEO

$223K+1.0%Aug 10
FLXNSell

Neil Bodick · Chief Scientific Officer

$1.3M−10.0%Jul 3
FLXNBuy

Neil Bodick · Chief Scientific Officer

$66K+1.0%Nov 22
FLXNBuy

Michael D. Clayman · President and CEO

$118K+1.0%Nov 9
FLXNBuy

Yamo Deniz · Chief Medical Officer

$132K+148.0%Sep 15
FLXNBuy

Samuel D Colella · Director and 10% owner

$85KJun 6
FLXNBuy

Michael D. Clayman · President and CEO

$86K+1.0%Jun 6
FLXNSell

Neil Bodick · Chief Medical Officer

$129K−1.0%May 19
FLXNSell

Neil Bodick · Chief Medical Officer

$141K−1.0%May 19
FLXNSell

Neil Bodick · Chief Medical Officer

$102K−1.0%May 19
FLXNSell

Neil Bodick · Chief Medical Officer

$96K−1.0%May 19
FLXNSell

Frederick W Driscoll · CFO

$69K−28.0%Mar 24
FLXNSell

Frederick W Driscoll · CFO

$668K−81.0%Mar 2
FLXNSell

Neil Bodick · Chief Medical Officer

$92K−1.0%Jan 23
FLXNSell

Neil Bodick · Chief Medical Officer

$185K−2.0%Dec 22
FLXNBuy

Samuel D Colella · Director and 10% owner

$164KDec 5
FLXNBuy

Michael D. Clayman · President and CEO

$30KNov 23
FLXNBuy

Michael D. Clayman · President and CEO

$31KNov 23
FLXNBuy

Samuel D Colella · Director and 10% owner

$600K+1.0%Nov 22
FLXNBuy

Michael D. Clayman · President and CEO

$30KNov 22
FLXNBuy

Barbara N Lubash · 10% owner

$10.0M−234.0%Jun 10
FLXNBuy

Versant Ventures Iii, LLC · 10% owner

$10.0M−234.0%Jun 10
FLXNBuy

Samuel D Colella · Director and 10% owner

$10.0M−234.0%Jun 10
About Horizon Flexible Income ETF

The fund is an actively managed ETF that seeks to achieve its investment objective by investing primarily in non-investment grade Fixed Income Instruments. The fund’s Fixed Income Instruments may include debt or debt-related securities, income producing securities, and other instruments or evidences of indebtedness, including bonds, bills, notes, loans, money market instruments, mortgage and asset backed securities, and preferred stocks, and derivative instruments related thereto; and other investment companies that invest primarily in the foregoing instruments.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.